Certara Q2 2026: Buyback, CCO, but Overvaluation Persists

What happened

Certara reported Q2 2026 results, completing its $100M share repurchase program and authorizing an additional $50M, while appointing Julien Perrier as Chief Commercial Officer. The company also reaffirmed its full-year 2026 revenue guidance, signaling management’s confidence in the outlook. These capital-return and leadership moves are incremental positives, but the deep value assessment highlights that the stock still trades at ~21x EV/EBITDA and above its DCF-implied value of ~$6.72. Despite a return to modest GAAP profitability and improving free cash flow, organic growth and net software retention remain modest, while the balance sheet carries over $1.2B in goodwill and thin interest coverage. Overall, the news does not address the core overvaluation or operational risks, leaving the investment thesis unchanged.

Implication

The completed $100M buyback and additional $50M authorization will modestly reduce the share count, but the impact on per-share metrics is limited given the still-high share base. Julien Perrier’s appointment as CCO could strengthen commercial execution over time, yet it is not a near-term catalyst that would accelerate growth materially. Reaffirmed revenue guidance suggests stability, but the lack of an upgrade underscores the modest growth environment and competitive pressures. With the equity still trading at a significant premium to its DCF-derived intrinsic value and interest coverage at just 1.1x, the margin of safety remains inadequate. Until there is clear evidence of durable, higher organic growth or a meaningful re-rating, the risk/reward does not favor entry, and the WAIT stance should be maintained.

Thesis delta

The appointment of a CCO and the extended buyback signal management’s confidence but do not alter the fundamental overvaluation or operational challenges. The thesis remains WAIT, as the stock still trades above intrinsic value and lacks a catalyst for sustainable organic growth acceleration.